Jerzy Gumulka
Director/Board Member en CNS PHARMACEUTICALS, INC. .
Fortuna: 15 568 $ al 31/03/2024
Perfil
Jerzy Gumulka is an Independent Director at CNS Pharmaceuticals, Inc. He previously worked as a Director at Moleculin LLC from 2010 to 2016.
Prior to that, he held the position of Technical Director at Kraton Polymers Do Brasil Industria e Comercio de Produtos from 2001 to 2015, and as a Technology Manager at Kraton Polymers U.S.
LLC from 2001 to 2016.
Dr. Gumulka obtained a doctorate degree from the University of Warsaw.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 08/04/2024 | 43 006 ( 0.51% ) | 15 568 $ | 31/03/2024 |
Cargos activos de Jerzy Gumulka
| Empresas | Cargo | Inicio |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Director/Board Member | 08/11/2017 |
Antiguos cargos conocidos de Jerzy Gumulka.
| Empresas | Cargo | Fin |
|---|---|---|
Kraton Polymers U.S. LLC
 Kraton Polymers U.S. LLC Chemicals: Major DiversifiedProcess Industries Kraton Polymers U.S. LLC engages in the manufacture of chemicals and adhesives. The company is headquartered in Houston, TX. | Chief Tech/Sci/R&D Officer | 01/06/2016 |
Moleculin LLC
 Moleculin LLC Pharmaceuticals: MajorHealth Technology Moleculin LLC develops dermatological products for treatment of skin disorders. The company was founded by Klemp V. Walter in 2006 and is headquartered in Houston, TX. | Director/Board Member | 01/01/2016 |
Kraton Polymers do Brasil SA
 Kraton Polymers do Brasil SA Miscellaneous ManufacturingProducer Manufacturing Part of DL Holdings Co., Ltd., Kraton Polymers do Brasil SA is a leading producer of styrenic block copolymers, specialty polymers, and high-value performance products derived from pine wood pulping co-products. The private company is based in São Paulo, Brazil. The Brazilian company conducts security vulnerability assessments at all sites and has been a preferred bitumen modifier for roofing products since the 1980s. In the 2000s, their bitumen modification with Kraton D polymers has delivered improved durability and resistance to rutting and low-temperature cracking. | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Formación de Jerzy Gumulka.
| University of Warsaw | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CNS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Moleculin LLC
Moleculin LLC Pharmaceuticals: MajorHealth Technology Moleculin LLC develops dermatological products for treatment of skin disorders. The company was founded by Klemp V. Walter in 2006 and is headquartered in Houston, TX. | Health Technology |
Kraton Polymers do Brasil SA
Kraton Polymers do Brasil SA Miscellaneous ManufacturingProducer Manufacturing Part of DL Holdings Co., Ltd., Kraton Polymers do Brasil SA is a leading producer of styrenic block copolymers, specialty polymers, and high-value performance products derived from pine wood pulping co-products. The private company is based in São Paulo, Brazil. The Brazilian company conducts security vulnerability assessments at all sites and has been a preferred bitumen modifier for roofing products since the 1980s. In the 2000s, their bitumen modification with Kraton D polymers has delivered improved durability and resistance to rutting and low-temperature cracking. | Producer Manufacturing |
Kraton Polymers U.S. LLC
Kraton Polymers U.S. LLC Chemicals: Major DiversifiedProcess Industries Kraton Polymers U.S. LLC engages in the manufacture of chemicals and adhesives. The company is headquartered in Houston, TX. | Process Industries |
- Bolsa de valores
- Insiders
- Jerzy Gumulka
